|
A case of absurd intelligence.
Spokesman Magazine
|
September 1, 2005|
|
COPYRIGHT 2005 U.S. Air Intelligence Agency. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.
(Hide copyright information)
Copyright
|
Europeans who followed current events and kept aware of international development should not have been taken by surprise when war broke out in Europe in 1914. For more than a decade, a series of events suggested preparations for an upcoming war were underway.
France and Germany disputed over Morocco, tensions soared within Great Britain when it appeared German naval expansion might someday challenge British naval supremacy, and Balkan instability effectively placed Austria-Hungary and Russia at odds with one another. All three of these issues and others generated ...
|
Ligand Pharmaceuticals and the SALK Institute Enter Settlement Agreement and Mutual Release of All Claims.
Business Wire
; SAN DIEGO -- Ligand Pharmaceuticals Incorporated (NASDAQ...ongoing arbitration between the parties. Ligand and SALK agreed to terminate their January...conveyance of rights to any third party. Ligand does not believe that it requires a license...
|
|
Ligand and Private Investors Complete Second Investment in X-Ceptor.
Business Wire
; ...BW HealthWire)--Oct. 7, 1999-- Ligand Pharmaceuticals Incorporated (Nasdaq...the field of orphan nuclear receptors. Ligand invested $3.2 million in cash and other...25 million. At the second closing, Ligand also issued to X-Ceptor investors...
|
|
LIGAND ELECTS TO RECEIVE MILESTONE PAYMENTS FROM PFIZER IN LIGAND COMMON STOCK; LIGAND COULD RETIRE OVER 101,000 SHARES
PR Newswire
; SAN DIEGO, May 7 /PRNewswire/ -- Ligand Pharmaceuticals Inc. (Nasdaq: LGND...from Pfizer Inc (NYSE: PFE) paid in Ligand stock, currently held by Pfizer. Under the terms of a recently settled lawsuit, Ligand has been deemed to have earned a second...
|
|
Ligand Exercises First Option to Buy Down ONTAK Royalties.
Business Wire
; SAN DIEGO -- Ligand Pharmaceuticals (NASDAQ:LGND) announced...royalties payable to Lilly on sales of Ligand's marketed cancer drug ONTAK(R) (denileukin diftitox) in the United States. Ligand recorded sales of $34.3 million for...
|
|
Ligand Pays Elan Milestone for Morphelan--TM-- NDA Submission.
Business Wire
; ...BW HealthWire)--June 8, 2000 Ligand Pharmaceuticals Incorporated (Nasdaq...plc (NYSE:ELN) 367,183 shares of Ligand common stock in connection with Elan...10.89, the average closing price of Ligand common stock for the five trading days...
|
|
Ligand Exercises Final Option to Buy Down ONTAK Royalties.
Business Wire
; SAN DIEGO -- Ligand Pharmaceuticals Incorporated (NASDAQ...royalties payable to Lilly on sales of Ligand's marketed cancer drug ONTAK(R) (denileukin diftitox) in the United States. Ligand will make a one-time cash payment of...
|
|
Ligand Restructures AVINZA License and Supply Agreement.
Business Wire
; ...Exchange for $100 Million Up-Front Payment Ligand to Purchase and Retire 2.2 Million Ligand Shares Held by Elan; Elan Agrees to 6-Month Lock-Up on 11.8 Million Remaining Shares Ligand Pharmaceuticals (Nasdaq: LGND) announced...
|
|
Ligand Terminates Long-Term Lease Obligation.
Business Wire
; ...Long-term Overhead Costs SAN DIEGO -- Ligand Pharmaceuticals Incorporated (NASDAQ...Diego. Under the terms of the agreement, Ligand will pay a termination fee of $14.3...million in April 2011. In addition, Ligand entered into a new lease for a period...
|
|
Ligand Issues $40.0 Million Zero Coupon Convertible Notes to Elan Corporation, plc.
Business Wire
; ...BW HealthWire)--July 15, 1999-- Ligand Pharmaceuticals Incorporated (Nasdaq...Agreement). The Notes are convertible into Ligand common stock at $14.00 per share...11.00. Under the Elan Agreement, Ligand may use the proceeds of the Note issuance...
|
|
Ligand and Elan Launch Strategic Alliance; Provides Ligand With Up To $130 Million in Funding, Rights to Morphelan for HIV and Oncology Markets.
Business Wire
; ...BW HealthWire)--Nov. 9, 1998--Ligand Pharmaceuticals Incorporated (Nasdaq:LGND...which Elan agreed to purchase $20 million of Ligand Common Stock and to purchase from Ligand up to $110 million in issue price of Zero Coupon...
|
Find more facts and information related to the
article "A case of absurd intelligence."